Janssen Pharmaceuticals

“Actio Biosciences, a San Diego-based biotech focused on neurological disorders, acquired by Jazz Pharmaceuticals for $820M upfront + up to $500M in earnouts.”

“Janssen from Janssen Pharmaceuticals. You know, he's considered one of the best drug developers of all times. He has these great videos on YouTube where he's interviewed 30, 40 years ago talking about regulatory capture in pharma.”